International Journal of Nephrology
Volume 2011 (2011), Article ID 982854, 9 pages
http://dx.doi.org/10.4061/2011/982854
Review Article
Calcific Uremic Arteriolopathy in Peritoneal Dialysis Populations
1Department of Nephrology, Royal Brisbane and Women’s Hospital, Queensland Health, Butterfield Street, Herston, QLD 4029, Australia
2Department of Anatomical Pathology, Royal Brisbane and Women’s Hospital, Queensland Health, Butterfield Street, Herston, QLD 4029, Australia
3School of Medicine, The University of Queensland, Brisbane, QLD 4027, Australia
Received 1 March 2011; Revised 11 April 2011; Accepted 14 April 2011
Academic Editor: Hulya Taskapan
Copyright © 2011 Nicholas New et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Linked References
- J. H. Bryant and W. H. White, “A case of calcification of the arteries and obliterative endarterities associated with hydronephrosis in a child age six months,” Guys Hospital Report, vol. 55: 1719, 1898. View at Google Scholar
- H. Selye, Calciphylaxis, University of Chicago Press, Chicago, Ill, USA, 1962.
- N. M. Rogers, D. J. O. Teubner, and P. T. H. Coates, “Calcific uremic arteriolopathy: advances in pathogenesis and treatment,” Seminars in Dialysis, vol. 20, no. 2, pp. 150–157, 2007. View at Publisher · View at Google Scholar · View at Scopus
- R. H. Weenig, L. D. Sewell, M. D. P. Davis, J. T. McCarthy, and M. R. Pittelkow, “Calciphylaxis: natural history, risk factor analysis, and outcome,” Journal of the American Academy of Dermatology, vol. 56, no. 4, pp. 569–579, 2007. View at Publisher · View at Google Scholar · View at Scopus
- W. A. Wilmer and C. M. Magro, “Calciphylaxis: rmerging concepts in prevention, diagnosis, and treatment,” Seminars in Dialysis, vol. 15, no. 3, pp. 172–186, 2002. View at Publisher · View at Google Scholar · View at Scopus
- R. Russell, M. A. Brookshire, M. Zekonis, and S. M. Moe, “Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca × P product and aggressive wound care,” Clinical Nephrology, vol. 58, no. 3, pp. 238–243, 2002. View at Google Scholar · View at Scopus
- A. R. Mazhar, R. J. Johnson, D. Gillen et al., “Risk factors and mortality associated with calciphylaxis in end-stage renal disease,” Kidney International, vol. 60, no. 1, pp. 324–332, 2001. View at Publisher · View at Google Scholar · View at Scopus
- R. L. Mehta, G. Scott, J. A. Sloand, and C. W. Francis, “Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis,” American Journal of Medicine, vol. 88, no. 3, pp. 252–257, 1990. View at Publisher · View at Google Scholar · View at Scopus
- S. U. Nigwekar, M. Wolf, R. H. Sterns, and J. K. Hix, “Calciphylaxis from nonuremic causes: a systematic review,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 4, pp. 1139–1143, 2008. View at Publisher · View at Google Scholar
- A. Fine and J. Zacharias, “Calciphylaxis is usually nonulcerating: risk factors, outcomes, and therapy,” Kidney International, vol. 61, no. 6, pp. 2210–2217, 2002. View at Google Scholar
- J. M. Zacharias, B. Fontaine, and A. Fine, “Calcium use increases risk of calciphylaxis: a case-control study,” Peritoneal Dialysis International, vol. 19, no. 3, pp. 248–252, 1999. View at Google Scholar · View at Scopus
- A. Fine and B. Fontaine, “Calciphylaxis: the beginning of the end?” Peritoneal Dialysis International, vol. 28, no. 3, pp. 268–270, 2008. View at Google Scholar
- J. S. Cicone, J. B. Petronis, C. D. Embert, and D. A. Spector, “Successful treatment of calciphylaxis with intravenous sodium thiosulfate,” American Journal of Kidney Diseases, vol. 43, no. 6, pp. 1104–1108, 2004. View at Google Scholar · View at Scopus
- D. Mataic and B. Bastani, “Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis,” Renal Failure, vol. 28, no. 4, pp. 361–363, 2006. View at Publisher · View at Google Scholar · View at Scopus
- O. H.D. Thang, E. H. Jaspars, and P. M. ter Wee, “Necrotizing mastitis caused by calciphylaxis,” Nephrology Dialysis Transplantation, vol. 21, no. 7, pp. 2020–2021, 2006. View at Publisher · View at Google Scholar
- N. Amin, E. Gonzalez, M. Lieber, I. B. Salusky, and J. J. Zaritsky, “Successful treatment of calcific uremic arteriolopathy in a pediatric dialysis patient,” Pediatric Nephrology, vol. 25, no. 2, pp. 357–362, 2010. View at Publisher · View at Google Scholar · View at Scopus
- E. Daudén and M. J. Oñate, “Calciphylaxis,” Dermatologic Clinics, vol. 26, no. 4, pp. 557–568, 2008. View at Publisher · View at Google Scholar · View at Scopus
- N. M. Rogers and P. T. H. Coates, “Calcific uraemic arteriolopathy: an update,” Current Opinion in Nephrology and Hypertension, vol. 17, no. 6, pp. 629–634, 2008. View at Publisher · View at Google Scholar · View at Scopus
- W. Bleibel, B. Hazar, and R. Herman, “A case report comparing various radiological tests in the diagnosis of calcific uremic arteriolopathy,” American Journal of Kidney Diseases, vol. 48, no. 4, pp. 659–661, 2006. View at Publisher · View at Google Scholar · View at Scopus
- S. H. Sakr, E. B. Russell, and H. E. Jasin, “Systematic lupus erythematosus and calciphylaxis,” Journal of Rheumatology, vol. 31, no. 9, pp. 1851–1853, 2004. View at Google Scholar · View at Scopus
- N. Igaki, R. Moriguchi, Y. Hirota et al., “Calciphylaxis in a patient with end-stage renal disease secondary to systemic lupus erythematosus associated with acral gangrene and mesenteric ischemia,” Internal Medicine, vol. 40, no. 12, pp. 1232–1237, 2001. View at Google Scholar · View at Scopus
- M. Angelis, L. L. Wong, S. A. Myers, and L. M. Wong, “Calciphylaxis in patients on hemodialysis: a prevalence study,” Surgery, vol. 122, no. 6, pp. 1083–1090, 1997. View at Publisher · View at Google Scholar
- A. J. Bleyer, M. Choi, B. Igwemezie, E. De La Torre, and W. L. White, “A case control study of proximal calciphylaxis,” American Journal of Kidney Diseases, vol. 32, no. 3, pp. 376–383, 1998. View at Google Scholar · View at Scopus
- T. Coates, G. S. Kirkland, R. B. Dymock et al., “Cutaneous necrosis from calcific uremic arteriolopathy,” American Journal of Kidney Diseases, vol. 32, no. 3, pp. 384–391, 1998. View at Google Scholar · View at Scopus
- C. M. Giachelli, M. Y. Speer, X. Li, R. M. Rajachar, and H. Yang, “Regulation of vascular calcification: roles of phosphate and osteopontin,” Circulation Research, vol. 96, no. 7, pp. 717–722, 2005. View at Publisher · View at Google Scholar · View at Scopus
- S. Jono, M. D. McKee, C. E. Murry et al., “Phosphate regulation of vascular smooth muscle cell calcification,” Circulation research, vol. 87, no. 7, pp. E10–E17, 2000. View at Google Scholar · View at Scopus
- H. Yang, G. Curinga, and C. M. Giachelli, “Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro,” Kidney International, vol. 66, no. 6, pp. 2293–2299, 2004. View at Publisher · View at Google Scholar · View at Scopus
- R. H. Weenig, “Pathogenesis of calciphylaxis: Hans Selye to nuclear factor κ-B,” Journal of the American Academy of Dermatology, vol. 58, no. 3, pp. 458–471, 2008. View at Publisher · View at Google Scholar · View at Scopus
- A. Y.-M. Wang, “Vascular and other tissue calcification in peritoneal dialysis patients,” Peritoneal Dialysis International, vol. 29, supplement 2, pp. S9–S14, 2009. View at Google Scholar
- M. Ketteler, P. Bongartz, R. Westenfeld et al., “Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study,” Lancet, vol. 361, no. 9360, pp. 827–833, 2003. View at Publisher · View at Google Scholar · View at Scopus
- G. Luo, P. Ducy, M. D. McKee et al., “Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protien,” Nature, vol. 386, no. 6620, pp. 78–81, 1997. View at Publisher · View at Google Scholar · View at Scopus
- M. M. H. Hermans, C. Vermeer, J. P. Kooman et al., “Undercarboxylated matrix GLA protein levels are decreased in dialysis patients and related to parameters of calcium-phosphate metabolism and aortic augmentation index,” Blood Purification, vol. 25, no. 5-6, pp. 395–401, 2008. View at Publisher · View at Google Scholar
- M. Farah, R. I. Crawford, A. Levin, and C. Chan Yan, “Calciphylaxis in the current era: emerging ‘ironic’ features?” Nephrology Dialysis Transplantation, vol. 26, no. 1, pp. 191–195, 2011. View at Publisher · View at Google Scholar
- S. Ahmed, K. D. Oneill, A. F. Hood, A. P. Evan, and S. M. Moe, “Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells,” American Journal of Kidney Diseases, vol. 37, no. 6, pp. 1267–1276, 2001. View at Google Scholar · View at Scopus
- A. S. Kang, J. T. McCarthy, C. Rowland et al., “Is calciphylaxis best treated surgically or medically?” Surgery, vol. 128, no. 6, pp. 967–972, 2000. View at Google Scholar · View at Scopus
- K. E. Chan, J. M. Lazarus, R. Thadhani, and R. M. Hakim, “Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients,” Journal of the American Society of Nephrology, vol. 20, no. 4, pp. 872–881, 2009. View at Publisher · View at Google Scholar · View at Scopus
- R. Levy, “Potential treatment of calciphylaxis with vitamin K2: comment on the article by Jacobs-Kosmin and DeHoratius,” Arthritis Care and Research, vol. 57, no. 8, pp. 1575–1576, 2007. View at Publisher · View at Google Scholar
- M. R. Chan, A. S. Yevzlin, M. Hinshaw, and J. B. Jaffery, “Calciphylaxis responsive to lanthanum carbonate (FOSRENOL) therapy,” Wisconsin Medical Journal, vol. 107, no. 7, pp. 335–338, 2008. View at Google Scholar
- F. Llach, “The evolving pattern of calciphylaxis: therapeutic considerations,” Nephrology Dialysis Transplantation, vol. 16, no. 3, pp. 448–451, 2001. View at Google Scholar · View at Scopus
- A. Duffy, M. Schurr, T. Warner, and H. Chen, “Long-term outcomes in patients with calciphylaxis from hyperparathyroidism,” Annals of Surgical Oncology, vol. 13, no. 1, pp. 96–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
- N. Velasco, M. S. MacGregor, A. Innes, and I. G. MacKay, “Successful treatment of calciphylaxis with cinacalcet—an alternative to parathyroidectomy?” Nephrology Dialysis Transplantation, vol. 21, no. 7, pp. 1999–2004, 2006. View at Publisher · View at Google Scholar · View at Scopus
- G. Elder, “The CARI guidelines. Biochemical and haematological targets: Parathyroid hormone,” 2006, http://www.cari.org.au/.
- C. G. Musso, P. Enz, F. Vidal et al., “Oral sodium thiosulfate solution as a secondary preventive treatment for calciphylaxis in dialysis patients,” Saudi Journal of Kidney Diseases and Transplantation, vol. 19, no. 5, pp. 820–821, 2008. View at Google Scholar · View at Scopus
- M. R. Hayden and D. J. A. Goldsmith, “Sodium thiosulfate: new hope for the treatment of calciphylaxis,” Seminars in Dialysis, vol. 23, no. 3, pp. 258–262, 2010. View at Publisher · View at Google Scholar
- M. Brucculeri, J. Cheigh, G. Bauer, and D. Serur, “Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis,” Seminars in Dialysis, vol. 18, no. 5, pp. 431–434, 2005. View at Publisher · View at Google Scholar · View at Scopus
- M. J. Courtney and N. Pannu, “Calcific uremic arteriolopathy should be treated conservatively,” Seminars in Dialysis, vol. 23, no. 1, pp. 34–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
- K. Subramaniam, H. Wallace, R. Sinniah, and B. Saker, “Complete resolution of recurrent calciphylaxis with long-term intravenous sodium thiosulfate,” Australasian Journal of Dermatology, vol. 49, no. 1, pp. 30–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
- N. M. Rogers and P. T. H. Coates, “Calcific uremic arteriolopathy—the argument for hyperbaric oxygen and sodium thiosulfate,” Seminars in Dialysis, vol. 23, no. 1, pp. 38–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
- C. Basile, A. Montanaro, M. Masi, G. Pati, P. De Maio, and A. Gismondi, “Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series,” Journal of Nephrology, vol. 15, no. 6, pp. 676–680, 2002. View at Google Scholar · View at Scopus
- T. Podymow, C. Wherrett, and K. D. Burns, “Hyperbaric oxygen in the treatment of calciphylaxis: a case series,” Nephrology Dialysis Transplantation, vol. 16, no. 11, pp. 2176–2180, 2001. View at Google Scholar · View at Scopus
- R. M. Leach, P. J. Rees, and P. Wilmshurst, “ABC of oxygen: hyperbaric oxygen therapy,” British Medical Journal, vol. 317, no. 7166, pp. 1140–1143, 1998. View at Google Scholar · View at Scopus
- T. Coates, G. S. Kirkland, R. B. Dymock et al., “Cutaneous necrosis from calcific uremic arteriolopathy,” American Journal of Kidney Diseases, vol. 32, no. 3, pp. 384–391, 1998. View at Google Scholar · View at Scopus
- P. Monney, Q. V. Nguyen, H. Perroud, and E. Descombes, “Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure,” Nephrology Dialysis Transplantation, vol. 19, no. 8, pp. 2130–2132, 2004. View at Publisher · View at Google Scholar · View at Scopus